Use of immune checkpoint inhibitors in combination with anti-aging drugs in preparation of tumor treatment products

Abstract

Use of immune checkpoint inhibitors in combination with anti-aging drugs in tumor treatment and tumor treatment products are disclosed, which provides a new drug and treatment strategy for effective treatment of tumors. The therapeutic effect of the provided treatment of ICIs in combination with the anti-aging drug is superior to that of the current treatment of ICIs treatment alone, and ICIs in combination with chemotherapy, etc. In the action process of ICIs in combination with the anti-aging drug, aging cells can be selectively removed, the aging state of an immune system thus is reversed. Accordingly, the inhibitory effect of tumor on the immune micro-environment is reduced, thus improving the treatment effect on various solid tumors. Based on the use or product provided by the present invention, new strategies and new ideas can be provided for further improving the clinical efficacy and prognosis of the solid tumors.

Dependencies are inferred from the claim text.